ARCHIVES

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

Gleevec Produces 59% Response Rate In Gastrointestinal Stromal Tumors

May 25, 2001

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006